文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

MicroRNA-494 通过靶向 PTEN 促进肿瘤扩增髓源性抑制细胞的积累和功能。

MicroRNA-494 is required for the accumulation and functions of tumor-expanded myeloid-derived suppressor cells via targeting of PTEN.

机构信息

Institute of Immunology, Zhejiang University School of Medicine, Hangzhou 310058, People's Republic of China.

出版信息

J Immunol. 2012 Jun 1;188(11):5500-10. doi: 10.4049/jimmunol.1103505. Epub 2012 Apr 27.


DOI:10.4049/jimmunol.1103505
PMID:22544933
Abstract

Myeloid-derived suppressor cells (MDSCs) potently suppress the anti-tumor immune responses and also orchestrate the tumor microenvironment that favors tumor angiogenesis and metastasis. The molecular networks regulating the accumulation and functions of tumor-expanded MDSCs are largely unknown. In this study, we identified microRNA-494 (miR-494), whose expression was dramatically induced by tumor-derived factors, as an essential player in regulating the accumulation and activity of MDSCs by targeting of phosphatase and tensin homolog (PTEN) and activation of the Akt pathway. TGF-β1 was found to be the main tumor-derived factor responsible for the upregulation of miR-494 in MDSCs. Expression of miR-494 not only enhanced CXCR4-mediated MDSC chemotaxis but also altered the intrinsic apoptotic/survival signal by targeting of PTEN, thus contributing to the accumulation of MDSCs in tumor tissues. Consequently, downregulation of PTEN resulted in increased activity of the Akt pathway and the subsequent upregulation of MMPs for facilitation of tumor cell invasion and metastasis. Knockdown of miR-494 significantly reversed the activity of MDSCs and inhibited the tumor growth and metastasis of 4T1 murine breast cancer in vivo. Collectively, our findings reveal that TGF-β1-induced miR-494 expression in MDSCs plays a critical role in the molecular events governing the accumulation and functions of tumor-expanded MDSCs and might be identified as a potential target in cancer therapy.

摘要

髓系来源的抑制性细胞(MDSCs)能够强烈抑制抗肿瘤免疫反应,还可以协调有利于肿瘤血管生成和转移的肿瘤微环境。调节肿瘤扩增 MDSC 积累和功能的分子网络在很大程度上是未知的。在这项研究中,我们发现了 microRNA-494(miR-494),其表达被肿瘤衍生因子显著诱导,作为通过靶向磷酸酶和张力蛋白同源物(PTEN)和激活 Akt 途径来调节 MDSC 积累和活性的重要参与者。TGF-β1 被发现是主要的肿瘤衍生因子,负责 MDSC 中 miR-494 的上调。miR-494 的表达不仅增强了 CXCR4 介导的 MDSC 趋化性,而且通过靶向 PTEN 改变了内在凋亡/存活信号,从而有助于 MDSC 在肿瘤组织中的积累。因此,PTEN 的下调导致 Akt 途径的活性增加,随后 MMPs 的上调促进肿瘤细胞的侵袭和转移。miR-494 的敲低显著逆转了 MDSC 的活性,并抑制了 4T1 小鼠乳腺癌在体内的生长和转移。总之,我们的研究结果表明,TGF-β1 诱导的 MDSC 中 miR-494 的表达在调节肿瘤扩增 MDSC 的积累和功能的分子事件中起着关键作用,可能被确定为癌症治疗的潜在靶点。

相似文献

[1]
MicroRNA-494 is required for the accumulation and functions of tumor-expanded myeloid-derived suppressor cells via targeting of PTEN.

J Immunol. 2012-4-27

[2]
MicroRNA-200c Promotes Suppressive Potential of Myeloid-Derived Suppressor Cells by Modulating PTEN and FOG2 Expression.

PLoS One. 2015-8-18

[3]
Immunosuppressive effects of hypoxia-induced glioma exosomes through myeloid-derived suppressor cells via the miR-10a/Rora and miR-21/Pten Pathways.

Oncogene. 2018-5-1

[4]
MicroRNA-155 and MicroRNA-21 promote the expansion of functional myeloid-derived suppressor cells.

J Immunol. 2014-1-3

[5]
MicroRNA-9 Regulates the Differentiation and Function of Myeloid-Derived Suppressor Cells via Targeting Runx1.

J Immunol. 2015-8-1

[6]
miR-223 suppresses differentiation of tumor-induced CD11b⁺ Gr1⁺ myeloid-derived suppressor cells from bone marrow cells.

Int J Cancer. 2011-3-25

[7]
MicroRNA-155 deficiency enhances the recruitment and functions of myeloid-derived suppressor cells in tumor microenvironment and promotes solid tumor growth.

Int J Cancer. 2015-3-15

[8]
Critical role of PPARγ in myeloid-derived suppressor cell-stimulated cancer cell proliferation and metastasis.

Oncotarget. 2016-1-12

[9]
MicroRNA-216a/217-induced epithelial-mesenchymal transition targets PTEN and SMAD7 to promote drug resistance and recurrence of liver cancer.

Hepatology. 2013-6-25

[10]
Inhibition of tumor-derived prostaglandin-e2 blocks the induction of myeloid-derived suppressor cells and recovers natural killer cell activity.

Clin Cancer Res. 2014-6-6

引用本文的文献

[1]
Interplay between tumor mutation burden and the tumor microenvironment predicts the prognosis of pan-cancer anti-PD-1/PD-L1 therapy.

Front Immunol. 2025-7-24

[2]
Integrating Genomics and Molecular Biology in Understanding Peritoneal Adhesion.

Curr Issues Mol Biol. 2025-6-19

[3]
Mir-494-3p enhances aggressive phenotype of non-small cell lung cancer cells by regulating SET/I2PP2A.

Sci Rep. 2025-5-2

[4]
The epigenetic hallmarks of immune cells in cancer.

Mol Cancer. 2025-3-5

[5]
Understanding the role of TNFR2 signaling in the tumor microenvironment of breast cancer.

J Exp Clin Cancer Res. 2024-11-28

[6]
Research progress on the role of PTEN deletion or mutation in the immune microenvironment of glioblastoma.

Front Oncol. 2024-8-14

[7]
MiRNAs as Regulators of Immune Cells in the Tumor Microenvironment of Ovarian Cancer.

Cells. 2024-8-13

[8]
Involvement of tumor immune microenvironment metabolic reprogramming in colorectal cancer progression, immune escape, and response to immunotherapy.

Front Immunol. 2024

[9]
Circulating Polymorphonuclear Myeloid-Derived Suppressor Cells (PMN-MDSCs) Have a Biological Role in Patients with Primary Myelofibrosis.

Cancers (Basel). 2024-7-16

[10]
Myeloid‑derived suppressor cells as targets of emerging therapies and nanotherapies (Review).

Med Int (Lond). 2024-6-25

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索